Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 17178294)

1.

Hepatocellular carcinoma: molecular biology and therapy.

Abou-Alfa GK.

Semin Oncol. 2006 Dec;33(6 Suppl 11):S79-83. Review.

2.
3.

Human hepatocellular carcinoma: expression profiles-based molecular interpretations and clinical applications.

Hui KM.

Cancer Lett. 2009 Dec 1;286(1):96-102. doi: 10.1016/j.canlet.2008.11.005. Epub 2008 Dec 17. Review.

PMID:
19095350
4.

New therapies for hepatocellular carcinoma.

Avila MA, Berasain C, Sangro B, Prieto J.

Oncogene. 2006 Jun 26;25(27):3866-84. Review.

PMID:
16799628
5.

Molecular pathogenesis of hepatocellular carcinoma.

McKillop IH, Moran DM, Jin X, Koniaris LG.

J Surg Res. 2006 Nov;136(1):125-35. Epub 2006 Oct 3. Review.

PMID:
17023002
6.

Opportunities for targeted therapies in hepatocellular carcinoma.

Thomas MB, Abbruzzese JL.

J Clin Oncol. 2005 Nov 1;23(31):8093-108. Review.

PMID:
16258107
7.

[Hepatocellular carcinoma: novel molecular aspects for differential diagnosis and therapy].

Kern MA, Schirmacher P.

Verh Dtsch Ges Pathol. 2006;90:85-98. Review. German.

PMID:
17867584
8.

Hepatocellular carcinoma: are we making progress?

Zhu AX.

Cancer Invest. 2003 Jun;21(3):418-28. Review.

PMID:
12901288
9.
10.

Immunotherapy of hepatocellular carcinoma.

Butterfield LH, Ribas A.

Expert Opin Biol Ther. 2002 Feb;2(2):123-33. Review.

PMID:
11849113
11.

Treatment options for hepatocellular carcinoma.

Sandhu DS, Tharayil VS, Lai JP, Roberts LR.

Expert Rev Gastroenterol Hepatol. 2008 Feb;2(1):81-92. doi: 10.1586/17474124.2.1.81. Review.

PMID:
19072372
12.

HCC heterogeneity: molecular pathogenesis and clinical implications.

Fransvea E, Paradiso A, Antonaci S, Giannelli G.

Cell Oncol. 2009;31(3):227-33. doi: 10.3233/CLO-2009-0473.

PMID:
19478390
13.
14.

Vascular endothelial growth factor monitoring in advanced hepatocellular carcinoma patients treated with radiofrequency ablation plus octreotide: a single center experience.

Montella L, Addeo R, Caraglia M, Faiola V, Guarrasi R, Vincenzi B, Palmeri A, Capasso E, Nocera V, Tarantino L, Ariete M, Martorelli A, Del Prete S.

Oncol Rep. 2008 Aug;20(2):385-90.

PMID:
18636202
15.

Management of early hepatocellular carcinoma in patients with well-compensated cirrhosis.

Cunningham SC, Tsai S, Marques HP, Mira P, Cameron A, Barroso E, Philosophe B, Pawlik TM.

Ann Surg Oncol. 2009 Jul;16(7):1820-31. doi: 10.1245/s10434-009-0364-1. Epub 2009 Mar 7.

PMID:
19267161
16.

Novel therapeutic approaches for hepatocellulcar carcinoma: fact and fiction.

Zhang YY, Xia HH.

World J Gastroenterol. 2008 Mar 21;14(11):1641-2.

17.

Pathogenesis of hepatocellular carcinoma and molecular therapies.

Mínguez B, Tovar V, Chiang D, Villanueva A, Llovet JM.

Curr Opin Gastroenterol. 2009 May;25(3):186-94. doi: 10.1097/MOG.0b013e32832962a1. Review.

PMID:
19387255
18.

Systemic therapies in hepatocellular carcinoma.

Wörns MA, Weinmann A, Schuchmann M, Galle PR.

Dig Dis. 2009;27(2):175-88. doi: 10.1159/000218351. Epub 2009 Jun 22. Review.

PMID:
19546557
19.

Gene- and immunotherapy for hepatocellular carcinoma.

Palmer DH, Hussain SA, Johnson PJ.

Expert Opin Biol Ther. 2005 Apr;5(4):507-23. Review.

PMID:
15934829
20.

Molecular mechanisms of hepatocellular carcinoma.

Aravalli RN, Steer CJ, Cressman EN.

Hepatology. 2008 Dec;48(6):2047-63. doi: 10.1002/hep.22580. Review.

PMID:
19003900
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk